lateral flow
Top Five Articles on 360Dx Last Week: Test for COPD Flare-Ups; Clinical Use of Wearable Techs; More
Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.
The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.
The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.
Healgen Gains FDA Marketing Authorization for OTC COVID, Flu A/B Test
The firm received de novo marketing authorization for its combination antigen test, and the developers of subsequent tests will be able to seek 510(k) clearance.
The company is seeking FDA de novo classification for the screening test, which is a capillary, blood-based lateral flow immunoassay.